Preclinical Pharmacokinetics, Pharmacodynamics and Safety of Sucroferric 
Oxyhydroxide

Sucroferric oxyhydroxide (VELPHORO(®)) is a polynuclear iron-based phosphate binder recently approved for the treatment of hyperphosphataemia in patients with chronic kidney disease (CKD). As a number of the available phosphate binders do not provide the optimal combination of good efficacy, adequat...

Descripción completa

Detalles Bibliográficos
Autores principales: Cozzolino, Mario, Funk, Felix, Rakov, Viatcheslav, Phan, Olivier, Teitelbaum, Isaac
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997947/
https://www.ncbi.nlm.nih.gov/pubmed/25658128
http://dx.doi.org/10.2174/1389200216666150206124424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997947/
https://www.ncbi.nlm.nih.gov/pubmed/25658128
http://dx.doi.org/10.2174/1389200216666150206124424

Ejemplares similares